IRIS
D'ALESSANDRO, MIRIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.894
NA - Nord America 11.468
AS - Asia 7.120
SA - Sud America 1.257
AF - Africa 494
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 33.267
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.194
IT - Italia 3.260
RU - Federazione Russa 3.249
SG - Singapore 2.363
CN - Cina 1.605
IE - Irlanda 1.562
GB - Regno Unito 1.373
BR - Brasile 1.034
VN - Vietnam 939
DE - Germania 829
HK - Hong Kong 746
SE - Svezia 657
FR - Francia 612
FI - Finlandia 480
IN - India 361
KR - Corea 288
ZA - Sudafrica 241
NL - Olanda 191
CA - Canada 141
ES - Italia 138
UA - Ucraina 117
BD - Bangladesh 113
JP - Giappone 108
IQ - Iraq 96
MX - Messico 86
PL - Polonia 86
CZ - Repubblica Ceca 74
CI - Costa d'Avorio 70
TR - Turchia 66
AR - Argentina 64
AT - Austria 53
PK - Pakistan 47
ID - Indonesia 41
IR - Iran 41
EG - Egitto 40
NG - Nigeria 39
CH - Svizzera 34
EC - Ecuador 34
UZ - Uzbekistan 33
KE - Kenya 32
SA - Arabia Saudita 32
MA - Marocco 31
AE - Emirati Arabi Uniti 30
VE - Venezuela 30
PH - Filippine 29
CL - Cile 24
AU - Australia 20
CO - Colombia 20
IL - Israele 20
JO - Giordania 20
MY - Malesia 19
BE - Belgio 18
LT - Lituania 18
PE - Perù 18
PT - Portogallo 17
BG - Bulgaria 14
TN - Tunisia 14
KZ - Kazakistan 13
PY - Paraguay 13
RO - Romania 13
AZ - Azerbaigian 12
GR - Grecia 12
NP - Nepal 12
EE - Estonia 11
HU - Ungheria 11
JM - Giamaica 11
LV - Lettonia 11
OM - Oman 10
PA - Panama 10
KG - Kirghizistan 9
BO - Bolivia 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
GE - Georgia 8
LB - Libano 8
UY - Uruguay 8
AL - Albania 7
DZ - Algeria 7
LK - Sri Lanka 7
MK - Macedonia 7
NO - Norvegia 7
BY - Bielorussia 6
CY - Cipro 6
ET - Etiopia 6
EU - Europa 6
QA - Qatar 6
CR - Costa Rica 5
PS - Palestinian Territory 5
SN - Senegal 5
TH - Thailandia 5
AM - Armenia 4
LA - Repubblica Popolare Democratica del Laos 4
GT - Guatemala 3
GY - Guiana 3
HR - Croazia 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
RS - Serbia 3
SV - El Salvador 3
Totale 33.224
Salva come PNG Salva come JPEG
Città #
Dallas 2.651
Dublin 1.531
Singapore 1.512
Southend 1.040
Moscow 989
Ashburn 928
Santa Clara 814
San Jose 706
Hong Kong 693
Chandler 621
Fairfield 460
Hefei 429
Siena 427
Beijing 403
Munich 374
Milan 373
Los Angeles 369
Lastra a Signa 363
Helsinki 321
Council Bluffs 309
Ho Chi Minh City 287
Seoul 279
New York 253
Hanoi 241
Johannesburg 220
Florence 219
Lauterbourg 213
Houston 196
Wilmington 191
Woodbridge 181
Princeton 179
Seattle 174
The Dalles 153
Cambridge 146
Rome 142
São Paulo 112
Chicago 102
Ann Arbor 100
Bengaluru 93
Shanghai 91
Orem 80
Frankfurt am Main 78
Tokyo 77
Buffalo 76
Lappeenranta 73
Warsaw 73
Abidjan 70
London 69
Turku 69
Nuremberg 68
Redondo Beach 67
Fremont 65
Düsseldorf 57
Málaga 57
Chennai 54
Portsmouth 54
San Mateo 54
Boardman 53
Da Nang 53
Jacksonville 49
San Diego 47
Dong Ket 44
Haiphong 44
Stockholm 44
Brooklyn 43
Montreal 43
Toronto 41
Amsterdam 39
Brno 39
Washington 39
Baghdad 38
Atlanta 37
Phoenix 37
Denver 35
Poplar 35
Manchester 34
Abuja 33
Naples 30
Paris 30
Rio de Janeiro 30
Tashkent 30
Boston 29
Brescia 29
Olomouc 28
Vienna 28
Mumbai 26
Mexico City 25
Salt Lake City 25
San Francisco 25
New Delhi 23
Newark 23
Dhaka 22
Zurich 22
Bologna 21
Hyderabad 21
Agliana 20
Gavirate 20
Guangzhou 20
Padova 20
Turin 20
Totale 21.420
Salva come PNG Salva come JPEG
Nome #
A first update on mapping the human genetic architecture of COVID-19 575
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 574
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 499
Genetic mechanisms of critical illness in COVID-19 409
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 387
An explainable model of host genetic interactions linked to COVID-19 severity 365
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 349
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 337
Pathogen-sugar interactions revealed by universal saturation transfer analysis 323
null 320
Peripheral biomarkers' panel for severe COVID-19 patients 316
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 311
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 309
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 292
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 291
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 286
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 283
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 279
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 273
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 271
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 271
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 253
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 253
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 250
Serial KL-6 measurements in COVID-19 patients 246
Prognostic bioindicators in severe COVID-19 patients 244
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting 243
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 242
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 235
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab 235
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 235
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 233
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 232
Alveolar nitric oxide as a biomarker of COVID-19 lung sequelae: A pivotal study 231
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 224
BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis 221
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 219
NK and NKT-like cells in granulomatous and fibrotic lung diseases 216
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 216
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases 215
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures 214
Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis 213
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 213
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 211
A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad 211
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II 211
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 204
Inflammatory muscle involvement in systemic vasculitis: A systematic review 204
WES profiling of COVID-19 204
Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19 203
Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy 202
Serum amyloid A: A potential biomarker of lung disorders 201
Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes 200
Whole-genome sequencing reveals host factors underlying critical COVID-19 198
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 196
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 195
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 194
A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist 193
Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence 192
Clinical and molecular characterization of COVID-19 hospitalized patients 192
Right cardiac involvement in lung diseases: a multimodality approach from diagnosis to prognostication 191
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution 191
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 189
Effects of rituximab therapy on B cell differentiation and depletion 188
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 187
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 187
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 187
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment 187
Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography 185
Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases 181
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab 180
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 179
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 176
Prognostic role of KL-6 in lymphangioleiomyomatosis patients 176
Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study : Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound 175
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review 175
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 174
Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis 174
Discordant liver fibrosis predictors in virologically suppressed people living with hiv without hepatitis virus infection 174
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study 173
Differential redox proteomic profiles of serum from severe asthma patients after one month of Benralizumab and Mepolizumab treatment 172
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study 171
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 171
CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients 169
Proteomic characterization of idiopathic pulmonary fibrosis patients: stable versus acute exacerbation 169
Common molecular pathways targeted by nintedanib in cancer and IPF: a bioinformatic study 169
Immunologic responses to antifibrotic treatment in IPF patients 165
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases 163
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant 162
Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a new protocol for investigating the mechanisms of idiopathic pulmonary fibrosis 160
Exploring the interaction between fractional exhaled nitric oxide and biologic treatment in severe asthma: a systematic review 159
Cytological analysis of bronchoalveolar lavage fluid in asbestos-exposed workers: BALF features in asbestos exposed workers 158
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy 157
Sarcoid Nodule or Lung Cancer? A High-Resolution Computed Tomography-Based Retrospective Study of Pulmonary Nodules in Patients with Sarcoidosis 154
Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of Interstitial Lung Disease 153
Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies 153
Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor 153
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study 153
Efficacy and safety of a step-down regimen of low dosage of glucocorticoids combined with early administration of synthetic or biologic immunosuppressants in anti-synthetase syndrome: A pilot study 151
Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy 151
Totale 22.656
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021480 0 0 0 0 0 0 0 0 0 108 195 177
2021/20222.169 160 237 194 146 106 100 87 109 96 286 231 417
2022/20232.800 181 305 334 279 157 479 308 236 176 138 121 86
2023/20243.278 121 95 325 187 177 689 908 166 50 115 135 310
2024/20257.553 629 300 842 417 853 452 416 440 588 364 687 1.565
2025/202615.910 1.173 2.244 2.104 2.064 3.393 645 2.196 539 640 912 0 0
Totale 34.109